Aptevo Therapeutics Inc. Financial Ratios — APVO Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-85.21	-47.89	-102.37	6.68	-58.2	-66.91	-33.19	-51.67	17.68	-58.96	-119.36	-121.38
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-126.06	- -	- -	- -
Gross Margin (%)	100	64.38	49.61	-24.86	65.82	51.39	- -	100	100	100	- -	- -	- -
EBITDA Margin (%)	-30,993.53	-108.42	-173.19	-644.95	-346.72	-213.62	- -	-605.43	-164.79	-890.82	- -	- -	- -
Operating Margin (%)	-31,385.29	-112.84	-181.84	-678.62	-368.05	-223.98	- -	-638.06	-174.1	-919.75	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	-46.4	- -	- -	- -	7.61	- -	- -
Pretax Margin (%)	-31,374.71	-113.33	-182.55	-1,397.93	-381.31	-232.75	- -	-717.64	-239.25	225.24	- -	- -	- -
Profit Margin (%)	-31,374.71	-112.02	-176.53	-1,125.84	47.57	-232.75	- -	-411.93	-231.51	257.77	- -	- -	- -
Net Income to Common Margin (%)	-31,374.71	-112.02	-176.53	-1,125.84	47.57	-232.75	- -	-411.93	-231.51	257.77	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	18	19	19	23	27	17	10	5	5	5
ST Debt	- -	- -	- -	- -	3	- -	20	5	12	2	- -	1	1
LT Debt	- -	- -	- -	18	16	19	3	22	5	8	5	5	4
Total Debt/EBITDA	- -	- -	- -	-0.29	-0.38	-0.39	-0.6	-1.05	-0.83	-0.34	-0.19	-0.22	-0.18
Net Debt/EBITDA	- -	0.07	0.08	-0.14	-0.24	0.23	-0.19	0.57	1.46	0.69	0.6	0.36	0.83
Total Debt/EBIT	- -	- -	- -	-0.27	-0.35	-0.37	-0.57	-1	-0.78	-0.33	-0.19	-0.22	-0.18
Net Debt/EBIT	- -	0.07	0.08	-0.13	-0.22	0.22	-0.18	0.54	1.39	0.67	0.59	0.35	0.82
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	- -	-143.93	-181.57	-87.82	-62.99	-188.74	-314.21	-346.54	-378.11	-602.04	-899.23	-1,587.41	-1,011.26
Long-Term Debt/Equity (%)	- -	- -	- -	36.35	19.17	63.4	28.09	135.07	415.13	41.92	44.16	97.35	21.65
Long-Term Debt/Capital (%)	- -	- -	- -	-29.51	-28.79	-17.83	-2.3	-14.17	-2.56	-3.84	-2.48	-1.91	-1.39
Long-Term Debt/Total Assets (%)	- -	- -	- -	20.01	13.44	28.56	6.23	41.86	8.92	22.02	21.73	29.69	13.84
Total Debt/Equity (%)	- -	- -	- -	36.35	23.24	63.4	195.83	165.2	1,374.59	53.05	44.16	113.5	26.63
Total Debt/Capital (%)	- -	- -	- -	-29.51	-34.89	-17.83	-16.04	-17.33	-8.47	-4.85	-2.48	-2.23	-1.71
Total Debt/Total Assets (%)	- -	- -	- -	20.01	16.29	28.56	43.42	51.2	29.53	27.87	21.73	34.62	17.02
Net Debt to Equity	- -	-3.8	-5.23	17.22	14.59	-37.35	62.62	-89.94	-2,439.97	-106.7	-138.32	-183.26	-124.38
Net Debt/Capital (%)	- -	2.04	1.96	-12.1	-19.38	8.19	-4.72	7.53	12.24	8.75	7.2	3.47	7.4
EBITDA	-53	-49	-58	-64	-51	-49	-39	-26	-20	-28	-28	-24	-26
EBITDA-CapEx	-54	-50	-60	-67	-52	-50	-39	-26	-21	-28	-28	-24	-26
Operating Income (Loss)	-53	-51	-61	-68	-54	-52	-41	-27	-21	-29	-29	-25	-26

Liquidity (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	0.18	0.23	2.79	4.36	1.74	0.33	2.75	1.3	2.6	2.34	1.4	3.57
Current Ratio	- -	2.09	1.76	3.65	5.14	2.76	0.78	3.25	1.51	3.15	2.64	1.72	3.82
Quick Ratio	- -	0.94	0.63	2.81	4.48	2.04	0.33	2.91	1.4	2.89	2.34	1.4	3.57
CFO/Avg Current Liab	- -	-4.74	-2.45	-1.87	-2.18	-2.85	-1.52	-1.11	-0.88	-0.97	-1.47	-3.54	-4.18
Common Equity/Total Assets	- -	-143.93	-181.57	-87.82	-62.99	-188.74	-314.21	-346.54	-378.11	-602.04	-899.23	-1,587.41	-1,011.26
Long-Term Debt/Equity (%)	- -	- -	- -	36.35	19.17	63.4	28.09	135.07	415.13	41.92	44.16	97.35	21.65
Long-Term Debt/Capital (%)	- -	- -	- -	-29.51	-28.79	-17.83	-2.3	-14.17	-2.56	-3.84	-2.48	-1.91	-1.39
Long-Term Debt/Total Assets (%)	- -	- -	- -	20.01	13.44	28.56	6.23	41.86	8.92	22.02	21.73	29.69	13.84
Total Debt/Equity (%)	- -	- -	- -	36.35	23.24	63.4	195.83	165.2	1,374.59	53.05	44.16	113.5	26.63
Total Debt/Capital (%)	- -	- -	- -	-29.51	-34.89	-17.83	-16.04	-17.33	-8.47	-4.85	-2.48	-2.23	-1.71
Total Debt/Total Assets (%)	- -	- -	- -	20.01	16.29	28.56	43.42	51.2	29.53	27.87	21.73	34.62	17.02
CFO/Total Liabilities	- -	-185.34	-124.55	-89.27	-118.88	-138.65	-101.97	-79.34	-39.14	-129.44	-92.94	-219.5	-260.8
CFO/CapEx	-50.33	-47.53	-31.93	-14.67	-29.65	-52.69	-277.01	-333.16	-30.41	-724.9	- -	- -	- -
Altman's Z-Score	- -	-7.6	-12.07	-2.53	-0.38	-4.3	-7.37	-3.29	-5.55	-9.89	-15.69	-26.75	-16.42

Working Capital (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	6.6	3.31	2.95	11.98	6.27	- -	1.23	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	55.27	110.13	123.61	30.48	58.24	- -	297.4	- -	- -	- -	- -	- -
Inventory Turnover	- -	1.84	0.89	1.2	6.73	7.97	5.03	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	197.89	408.98	304.23	54.24	45.78	72.57	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	5.91	1.82	-1.47	1.52	1.26	1.96	-0.94	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	61.8	200.41	-248.9	240.52	289.98	185.75	-387.74	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	191.37	318.7	676.74	-155.8	-185.96	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	-142.62	-298.86	-180.62	-23.76	12.46	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	18	20	- -	1	2	6	- -	- -	- -	- -	- -	- -
Raw Materials	- -	8	7	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	3	5	- -	- -	1	2	- -	- -	- -	- -	- -	- -
Finished Goods	- -	6	9	- -	- -	1	4	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	40	70	21	27	150	37	15	4	6	3
- Cash & Cash Equivalents	- -	4	5	10	7	31	12	40	45	23	17	9	22
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	18	19	19	23	27	17	10	5	5	5
Enterprise Value	- -	-4	-5	4	8	9	38	138	9	2	-8	3	-14
Total Capital	- -	-173	-232	-62	-55	-108	-145	-158	-197	-196	-218	-242	-270
Total Debt/Capital (%)	- -	- -	- -	-29.51	-34.89	-17.83	-16.04	-17.33	-8.47	-4.85	-2.48	-2.23	-1.71
Total Debt / EV	- -	- -	- -	4.71	2.43	2.03	0.62	0.2	1.95	5.14	-0.67	1.82	-0.33
EV/Sales	- -	- -	- -	0.39	0.54	0.41	- -	31.98	0.7	0.6	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	40	70	21	27	150	37	15	4	6	3
Diluted Enterprise Value	- -	-4	-5	49	82	9	38	138	9	2	-8	3	-14
EV per Share	- -	- -	- -	1,949,492	3,928,708	4,742,002	7,522,753.5	19,684,832	1,071,324.5	168,796.54	293.14	732.79	- -
TTM Sales	- -	46	34	10	15	23	- -	4	12	3	- -	- -	- -
TTM EBITDA	-53	-49	-58	-64	-51	-49	-39	-26	-20	-28	-28	-24	-26
TTM Operating Income	-53	-51	-61	-68	-54	-52	-41	-27	-21	-29	-29	-25	-26
TTM Cash Flow to Firm	-51	-47	-49	-37	-42	-51	-42	-29	-22	-21	-12	-24	-26
TTM Free Cash Flow to Firm	-50	-46	-47	-34	-40	-50	-42	-29	-21	-21	-12	-24	-26

Multiples (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	-1.17	-1.73	-0.41	-0.64	-5.14	-1.76	-0.71	-0.3	-0.26	-0.12
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	-4	-5	4	8	9	38	138	9	2	-8	3	-14
Low Price	- -	- -	- -	13,866,653	9,419,478	9,107,683	4,020,508.75	1,723,075.25	3,739,190.5	1,136,995.25	89,084.16	1,314	9.07
EV/Sales	- -	- -	- -	0.39	0.54	0.41	- -	31.98	0.7	0.6	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	9.98	- -	- -	- -	- -	1.86	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-0.39	5.33	-1.24	-0.9	-2.78	-3.67	3.43	-1.31	-4.36	-4.44
Price/Earnings High	- -	- -	- -	-1.21	10.59	-1.94	-2.03	-13.87	-7.12	6.87	-2.87	-24.15	-24.02
Price/Earnings Low	- -	- -	- -	-0.25	2.7	-0.34	-0.5	-0.68	-1.05	1.56	-0.17	-0.22	-0.11
Price/Book Value	- -	- -	- -	-0.5	-0.94	-0.16	-0.16	-0.81	-0.17	-0.07	-0.02	-0.03	-0.01
Price/Book Value Average	- -	- -	- -	-0.55	-0.5	-0.52	-0.22	-0.27	-0.49	-0.13	-0.1	-0.42	-0.42
Price/Book Value High	- -	- -	- -	-1.69	-1	-0.82	-0.49	-1.33	-0.95	-0.27	-0.22	-2.35	-2.27
Price/Book Value Low	- -	- -	- -	-0.34	-0.26	-0.14	-0.12	-0.07	-0.14	-0.06	-0.01	-0.02	-0.01
Price/Tangible Book Value	- -	- -	- -	0.92	0.92	0.83	3.62	9.06	30.35	0.83	0.29	1.32	0.17
Price/Tangible Book Value Average	- -	- -	- -	1.01	0.49	2.64	4.93	2.98	85.78	1.53	1.87	22.11	6.63
Price/Tangible Book Value High	- -	- -	- -	3.12	0.97	4.14	11.06	14.83	166.61	3.07	4.08	122.56	35.88
Price/Tangible Book Value Low	- -	- -	- -	0.64	0.25	0.72	2.71	0.73	24.6	0.7	0.24	1.12	0.16
Price/Sales	- -	- -	- -	4.01	4.75	0.9	- -	34.89	3	4.8	- -	- -	- -
Price/Sales Average	- -	- -	- -	4.43	2.53	2.88	- -	11.47	8.49	8.84	- -	- -	- -
Price/Sales High	- -	- -	- -	13.62	5.04	4.52	- -	57.13	16.48	17.7	- -	- -	- -
Price/Sales Low	- -	- -	- -	2.78	1.29	0.79	- -	2.8	2.43	4.02	- -	- -	- -
Price/Cash Flow	- -	- -	- -	-1.09	-1.67	-0.41	-0.63	-5.13	-1.7	-0.71	-0.3	-0.26	-0.12
Price/Cash Flow Average	- -	- -	- -	-1.2	-0.89	-1.29	-0.86	-1.69	-4.81	-1.31	-1.94	-4.42	-4.5
Price/Cash Flow High	- -	- -	- -	-3.69	-1.78	-2.03	-1.94	-8.4	-9.35	-2.62	-4.25	-24.5	-24.37
Price/Cash Flow Low	- -	- -	- -	-0.75	-0.45	-0.35	-0.47	-0.41	-1.38	-0.59	-0.25	-0.22	-0.11
Price/Free Cash Flow Average	- -	- -	- -	-1.29	-0.92	-1.32	-0.87	-1.69	-4.97	-1.31	-1.94	-4.42	-4.5
Price/Free Cash Flow High	- -	- -	- -	-3.96	-1.84	-2.07	-1.94	-8.42	-9.66	-2.63	-4.25	-24.5	-24.37
Price/Free Cash Flow Low	- -	- -	- -	-0.81	-0.47	-0.36	-0.48	-0.41	-1.43	-0.6	-0.25	-0.22	-0.11
EV/Sales Average	- -	- -	- -	5.3	3.35	2.39	- -	8.56	6.18	4.63	- -	- -	- -
EV/Sales High	- -	- -	- -	14.5	5.85	4.03	- -	54.21	14.18	13.49	- -	- -	- -
EV/Sales Low	- -	- -	- -	3.65	2.1	0.3	- -	0.09	0.13	113.36	- -	- -	- -
EV/EBITDA Average	- -	0.07	0.08	-0.82	-0.97	-1.12	-1.22	-1.41	-3.75	-0.52	-0.4	-4.2	-3.77
EV/EBITDA High	- -	0.07	0.08	-2.25	-1.69	-1.88	-2.4	-8.95	-8.6	-1.51	-1.36	-23.89	-23.27
EV/EBITDA Low	- -	0.07	0.08	-0.57	-0.61	-0.14	-0.8	0.02	-0.08	0.02	0.3	-0.08	0.54
EV/EBIT Average	- -	0.07	0.08	-0.78	-0.91	-1.07	-1.16	-1.34	-3.55	-0.5	-0.39	-4.14	-3.73
EV/EBIT High	- -	0.07	0.08	-2.14	-1.59	-1.8	-2.27	-8.5	-8.14	-1.47	-1.33	-23.55	-23.06
EV/EBIT Low	- -	0.07	0.08	-0.54	-0.57	-0.13	-0.75	0.02	-0.07	0.02	0.3	-0.08	0.54
Last Price	- -	- -	- -	20,020,492	34,789,708	10,420,502	5,374,353.5	21,479,832	4,612,449.5	1,359,705.63	106,080.48	1,551.6	9.43
High Price	- -	- -	- -	68,020,448	36,923,040	52,102,512	16,410,240	35,164,800	25,324,516	5,010,984	1,512,086.38	143,856	1,976.4
Enterprise Value Average	- -	-4	-5	53	49	55	47	37	76	14	11	102	98
Enterprise Value High	- -	-4	-5	145	86	93	93	234	174	42	38	579	607
Enterprise Value Low	- -	-4	-5	36	31	7	31	-1	2	-1	-9	2	-14

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	85,000	22,815,500	16,800,500	4,992,500	7,329,000	11,533,500	- -	615,571.43	1,536,500	283,090.91	- -	- -	- -
EBITDA per Share	-26,344,500	-24,735,500	-29,096,500	-32,199,000	-25,411,000	-24,637,500	-7,745,400	-3,726,857.14	-2,532,000	-2,521,818.18	-857,909.09	-5,986.18	-82.63
Operating Income per Share	-26,677,500	-25,746,000	-30,550,000	-33,880,000	-26,974,500	-25,832,500	-8,192,400	-3,927,714.29	-2,675,000	-2,603,727.27	-875,090.91	-6,073.07	-83.39
Basic EPS, GAAP	-26,668,500	-25,557,500	-29,658,500	-56,207,500	3,486,500	-26,844,500	-8,089,600	-2,535,714.29	-3,557,125	729,727.27	-527,606.06	-5,956.55	-82.3
Basic EPS from Cont Ops	-26,668,500	-25,557,500	-29,658,500	-59,945,500	-16,296,000	-26,844,500	-8,612,800	-4,417,571.43	-3,676,000	637,636.36	-565,151.52	-5,956.55	-82.3
Diluted EPS, GAAP	-26,668,500	-25,557,500	-29,658,500	-56,207,500	3,486,500	-26,844,500	-8,089,600	-2,535,714.29	-3,557,125	729,727.27	-527,606.06	-5,956.55	-82.3
Diluted EPS from Cont Ops	-26,668,500	-25,557,500	-29,658,500	-59,945,500	-16,296,000	-26,844,500	-8,612,800	-4,417,571.43	-3,676,000	637,636.36	-565,151.52	-5,956.55	-82.3
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-25,696,000	-23,503,500	-24,380,000	-18,431,000	-20,786,500	-25,711,000	-8,476,600	-4,188,285.71	-2,709,875	-1,911,090.91	-355,454.55	-5,871.39	-81.11
Free Cash Flow per Basic Share	-26,206,500	-23,998,000	-25,143,500	-19,687,000	-21,487,500	-26,199,000	-8,507,200	-4,200,857.14	-2,799,000	-1,913,727.27	-355,454.55	-5,871.39	-81.11
Cash & Equivalents per Share	- -	1,796,500	2,318,500	27,262,500	40,391,500	15,317,500	2,489,600	5,711,285.71	5,630,500	2,057,727.27	512,242.42	2,151.07	68.52
Book Value per Share	- -	-86,335,500	-115,994,000	-40,336,000	-36,848,500	-63,692,500	-33,562,200	-26,508,571.43	-26,752,000	-18,726,181.82	-6,769,272.73	-61,094.3	-871.54
Tangible Book Value per Share	- -	9,695,000	82,000	21,828,000	37,977,500	12,578,000	1,484,400	2,370,571.43	152,000	1,634,000	370,333.33	1,173.78	55.08

Aptevo Therapeutics Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)